PATENT CLAIM ANALYSIS

Application Number: 15780898
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
A method for selecting cancer patient for treatment with Seneca Valley Virus (SVV) by determining expression of ANTXR1 in a cancerous tissue in a cancer patient; and designating the cancer patient as a candidate for treatment with SVV if normal levels or elevated levels of ANTXR1 expression is detected in the cancerous tissue. Also a method for treating a cancer patient with SVV is disclosed.

Claim (Index 12):
The method of  claim 11 , wherein the therapeutic agent is a checkpoint inhibitors.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 1.75
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13209124', '12576296', '14427918', '15451374', '16068826']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6812703065627425
- 35 USC 102 Novelty (BERT): 0.4950598272264382
- Combined Prediction Score: 0.6626492586291121
- Mean Citation Score: 201.244464
- Max Citation Score: 210.40155
- Similarity Product: 156.40606154712438

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test